nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—ulcerative colitis	0.388	1	CbGaD
Mebendazole—CYP1A1—Nicotine—ulcerative colitis	0.0929	0.168	CbGbCtD
Mebendazole—CYP1A1—Cholecalciferol—ulcerative colitis	0.0834	0.151	CbGbCtD
Mebendazole—CYP3A4—Budesonide—ulcerative colitis	0.05	0.0906	CbGbCtD
Mebendazole—ABCB1—Methylprednisolone—ulcerative colitis	0.0373	0.0675	CbGbCtD
Mebendazole—CYP1A1—Dexamethasone—ulcerative colitis	0.0361	0.0654	CbGbCtD
Mebendazole—ABCB1—Betamethasone—ulcerative colitis	0.0242	0.0439	CbGbCtD
Mebendazole—ABCB1—Prednisolone—ulcerative colitis	0.0239	0.0433	CbGbCtD
Mebendazole—ABCB1—Hydrocortisone—ulcerative colitis	0.0227	0.0411	CbGbCtD
Mebendazole—ABCB1—Prednisone—ulcerative colitis	0.0226	0.0409	CbGbCtD
Mebendazole—CYP3A4—Methylprednisolone—ulcerative colitis	0.0223	0.0404	CbGbCtD
Mebendazole—CYP3A4—Nicotine—ulcerative colitis	0.0217	0.0394	CbGbCtD
Mebendazole—CYP3A4—Cholecalciferol—ulcerative colitis	0.0195	0.0354	CbGbCtD
Mebendazole—CYP3A4—Triamcinolone—ulcerative colitis	0.0169	0.0307	CbGbCtD
Mebendazole—CYP3A4—Betamethasone—ulcerative colitis	0.0145	0.0263	CbGbCtD
Mebendazole—CYP3A4—Prednisolone—ulcerative colitis	0.0143	0.0259	CbGbCtD
Mebendazole—ABCB1—Dexamethasone—ulcerative colitis	0.0141	0.0255	CbGbCtD
Mebendazole—CYP3A4—Hydrocortisone—ulcerative colitis	0.0136	0.0246	CbGbCtD
Mebendazole—CYP3A4—Prednisone—ulcerative colitis	0.0135	0.0245	CbGbCtD
Mebendazole—CYP3A4—Dexamethasone—ulcerative colitis	0.00844	0.0153	CbGbCtD
Mebendazole—TUBA1A—Loss of Nlp from mitotic centrosomes—CEP72—ulcerative colitis	0.00256	0.0751	CbGpPWpGaD
Mebendazole—TUBA1A—Centrosome maturation—CEP72—ulcerative colitis	0.00227	0.0665	CbGpPWpGaD
Mebendazole—Ketoprofen—CXCR1—ulcerative colitis	0.00225	0.262	CrCbGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—ARPC2—ulcerative colitis	0.00217	0.0637	CbGpPWpGaD
Mebendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—CEP72—ulcerative colitis	0.00208	0.0611	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—CEP72—ulcerative colitis	0.00156	0.0459	CbGpPWpGaD
Mebendazole—TUBB4B—Loss of Nlp from mitotic centrosomes—CEP72—ulcerative colitis	0.00155	0.0454	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—CEP72—ulcerative colitis	0.00154	0.0452	CbGpPWpGaD
Mebendazole—TUBB4B—Centrosome maturation—CEP72—ulcerative colitis	0.00137	0.0402	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—ARPC2—ulcerative colitis	0.00131	0.0385	CbGpPWpGaD
Mebendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—CEP72—ulcerative colitis	0.00126	0.0369	CbGpPWpGaD
Mebendazole—TUBA1A—epithelium—ulcerative colitis	0.00104	0.126	CbGeAlD
Mebendazole—TUBA1A—smooth muscle tissue—ulcerative colitis	0.001	0.121	CbGeAlD
Mebendazole—TUBB4B—G2/M Transition—CEP72—ulcerative colitis	0.000945	0.0277	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—CEP72—ulcerative colitis	0.000932	0.0273	CbGpPWpGaD
Mebendazole—Ketorolac—PTGS1—ulcerative colitis	0.000924	0.107	CrCbGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CD14—ulcerative colitis	0.00084	0.0246	CbGpPWpGaD
Mebendazole—TUBA1A—lymphoid tissue—ulcerative colitis	0.0008	0.097	CbGeAlD
Mebendazole—TUBA1A—digestive system—ulcerative colitis	0.00079	0.0959	CbGeAlD
Mebendazole—Tiaprofenic acid—PTGS1—ulcerative colitis	0.000753	0.0876	CrCbGaD
Mebendazole—Nepafenac—PTGS1—ulcerative colitis	0.000716	0.0833	CrCbGaD
Mebendazole—Bopindolol—ADRB2—ulcerative colitis	0.000716	0.0833	CrCbGaD
Mebendazole—Albendazole—ABCB1—ulcerative colitis	0.000697	0.081	CrCbGaD
Mebendazole—TUBB4B—smooth muscle tissue—ulcerative colitis	0.000667	0.0809	CbGeAlD
Mebendazole—TUBA1A—liver—ulcerative colitis	0.000589	0.0714	CbGeAlD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—TLR4—ulcerative colitis	0.000576	0.0169	CbGpPWpGaD
Mebendazole—Ketoprofen—CXCL8—ulcerative colitis	0.000569	0.0662	CrCbGaD
Mebendazole—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000536	0.0157	CbGpPWpGaD
Mebendazole—TUBB4B—lymphoid tissue—ulcerative colitis	0.000533	0.0647	CbGeAlD
Mebendazole—Menorrhagia—Mesalazine—ulcerative colitis	0.000529	0.0548	CcSEcCtD
Mebendazole—Ketorolac—PTGS2—ulcerative colitis	0.000528	0.0614	CrCbGaD
Mebendazole—TUBB4B—digestive system—ulcerative colitis	0.000527	0.0639	CbGeAlD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CD14—ulcerative colitis	0.000507	0.0149	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.000498	0.0146	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CDH1—ulcerative colitis	0.000488	0.0143	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CEP72—ulcerative colitis	0.000445	0.013	CbGpPWpGaD
Mebendazole—Tiaprofenic acid—PTGS2—ulcerative colitis	0.000431	0.0501	CrCbGaD
Mebendazole—TUBA1A—Metabolism of proteins—MUC3A—ulcerative colitis	0.000424	0.0124	CbGpPWpGaD
Mebendazole—Nepafenac—PTGS2—ulcerative colitis	0.00041	0.0476	CrCbGaD
Mebendazole—TUBB4B—liver—ulcerative colitis	0.000392	0.0476	CbGeAlD
Mebendazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000389	0.0114	CbGpPWpGaD
Mebendazole—CYP1A1—epithelium—ulcerative colitis	0.000388	0.047	CbGeAlD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ulcerative colitis	0.000348	0.0102	CbGpPWpGaD
Mebendazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000345	0.0101	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—RELA—ulcerative colitis	0.00031	0.00909	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000308	0.00904	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.000301	0.00881	CbGpPWpGaD
Mebendazole—CYP1A1—digestive system—ulcerative colitis	0.000295	0.0358	CbGeAlD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CDH1—ulcerative colitis	0.000295	0.00864	CbGpPWpGaD
Mebendazole—Ketoprofen—PTGS1—ulcerative colitis	0.00029	0.0338	CrCbGaD
Mebendazole—Angioedema—Nicotine—ulcerative colitis	0.000279	0.0289	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle—CEP72—ulcerative colitis	0.000269	0.00788	CbGpPWpGaD
Mebendazole—Convulsion—Nicotine—ulcerative colitis	0.000265	0.0274	CcSEcCtD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00026	0.00763	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000259	0.00759	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MUC3A—ulcerative colitis	0.000256	0.00751	CbGpPWpGaD
Mebendazole—Neutropenia—Mesalazine—ulcerative colitis	0.00023	0.0238	CcSEcCtD
Mebendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000229	0.0067	CbGpPWpGaD
Mebendazole—Agranulocytosis—Azathioprine—ulcerative colitis	0.000224	0.0233	CcSEcCtD
Mebendazole—CYP1A1—liver—ulcerative colitis	0.00022	0.0267	CbGeAlD
Mebendazole—CYP3A4—digestive system—ulcerative colitis	0.000216	0.0263	CbGeAlD
Mebendazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000213	0.00624	CbGpPWpGaD
Mebendazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000212	0.00622	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MUC2—ulcerative colitis	0.000207	0.00608	CbGpPWpGaD
Mebendazole—Agranulocytosis—Mesalazine—ulcerative colitis	0.000204	0.0212	CcSEcCtD
Mebendazole—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000204	0.0211	CcSEcCtD
Mebendazole—ABCB1—epithelium—ulcerative colitis	0.000201	0.0244	CbGeAlD
Mebendazole—Urticaria—Nicotine—ulcerative colitis	0.000198	0.0205	CcSEcCtD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000198	0.0058	CbGpPWpGaD
Mebendazole—Abdominal pain—Nicotine—ulcerative colitis	0.000197	0.0204	CcSEcCtD
Mebendazole—Hepatitis—Mesalazine—ulcerative colitis	0.000197	0.0204	CcSEcCtD
Mebendazole—Angioedema—Budesonide—ulcerative colitis	0.000192	0.0199	CcSEcCtD
Mebendazole—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.00019	0.0197	CcSEcCtD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000187	0.00548	CbGpPWpGaD
Mebendazole—Hypersensitivity—Nicotine—ulcerative colitis	0.000184	0.019	CcSEcCtD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000182	0.00535	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000182	0.00533	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000182	0.00533	CbGpPWpGaD
Mebendazole—Ketoprofen—PTGS2—ulcerative colitis	0.000166	0.0193	CrCbGaD
Mebendazole—Rash—Mercaptopurine—ulcerative colitis	0.000162	0.0168	CcSEcCtD
Mebendazole—Dermatitis—Mercaptopurine—ulcerative colitis	0.000162	0.0168	CcSEcCtD
Mebendazole—CYP3A4—liver—ulcerative colitis	0.000161	0.0196	CbGeAlD
Mebendazole—Rash—Nicotine—ulcerative colitis	0.000157	0.0163	CcSEcCtD
Mebendazole—Dermatitis—Nicotine—ulcerative colitis	0.000157	0.0163	CcSEcCtD
Mebendazole—Angioedema—Mesalazine—ulcerative colitis	0.000156	0.0162	CcSEcCtD
Mebendazole—ABCB1—lymphoid tissue—ulcerative colitis	0.000155	0.0188	CbGeAlD
Mebendazole—ABCB1—digestive system—ulcerative colitis	0.000153	0.0186	CbGeAlD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000152	0.00446	CbGpPWpGaD
Mebendazole—Ketoprofen—ALB—ulcerative colitis	0.000148	0.0172	CrCbGaD
Mebendazole—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000144	0.00423	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000141	0.0146	CcSEcCtD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000138	0.00404	CbGpPWpGaD
Mebendazole—Urticaria—Budesonide—ulcerative colitis	0.000136	0.0141	CcSEcCtD
Mebendazole—Abdominal pain—Budesonide—ulcerative colitis	0.000136	0.0141	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000134	0.00393	CbGpPWpGaD
Mebendazole—CYP1A1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000134	0.00393	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidative Stress—NFKB1—ulcerative colitis	0.00013	0.00382	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—GHRL—ulcerative colitis	0.00013	0.00382	CbGpPWpGaD
Mebendazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000128	0.00376	CbGpPWpGaD
Mebendazole—Hypersensitivity—Budesonide—ulcerative colitis	0.000127	0.0131	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000126	0.0037	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000125	0.013	CcSEcCtD
Mebendazole—TUBB4B—Metabolism of proteins—MUC2—ulcerative colitis	0.000125	0.00367	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000122	0.00358	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000122	0.00357	CbGpPWpGaD
Mebendazole—Neutropenia—Prednisone—ulcerative colitis	0.000122	0.0126	CcSEcCtD
Mebendazole—Abdominal pain—Azathioprine—ulcerative colitis	0.000121	0.0126	CcSEcCtD
Mebendazole—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000114	0.0118	CcSEcCtD
Mebendazole—ABCB1—liver—ulcerative colitis	0.000114	0.0138	CbGeAlD
Mebendazole—Angioedema—Prednisolone—ulcerative colitis	0.000114	0.0118	CcSEcCtD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000113	0.00332	CbGpPWpGaD
Mebendazole—Hypersensitivity—Azathioprine—ulcerative colitis	0.000113	0.0117	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000111	0.00326	CbGpPWpGaD
Mebendazole—Angioedema—Hydrocortisone—ulcerative colitis	0.000111	0.0115	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000111	0.00325	CbGpPWpGaD
Mebendazole—Urticaria—Mesalazine—ulcerative colitis	0.000111	0.0115	CcSEcCtD
Mebendazole—Abdominal pain—Mesalazine—ulcerative colitis	0.00011	0.0114	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.00011	0.00322	CbGpPWpGaD
Mebendazole—Rash—Budesonide—ulcerative colitis	0.000108	0.0112	CcSEcCtD
Mebendazole—Dermatitis—Budesonide—ulcerative colitis	0.000108	0.0112	CcSEcCtD
Mebendazole—Convulsion—Prednisolone—ulcerative colitis	0.000108	0.0112	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	0.000107	0.00313	CbGpPWpGaD
Mebendazole—Convulsion—Hydrocortisone—ulcerative colitis	0.000105	0.0109	CcSEcCtD
Mebendazole—Angioedema—Triamcinolone—ulcerative colitis	0.000105	0.0109	CcSEcCtD
Mebendazole—Angioedema—Methylprednisolone—ulcerative colitis	0.000105	0.0108	CcSEcCtD
Mebendazole—Hypersensitivity—Mesalazine—ulcerative colitis	0.000103	0.0107	CcSEcCtD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	9.98e-05	0.00293	CbGpPWpGaD
Mebendazole—Convulsion—Triamcinolone—ulcerative colitis	9.93e-05	0.0103	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	9.93e-05	0.00291	CbGpPWpGaD
Mebendazole—Convulsion—Methylprednisolone—ulcerative colitis	9.91e-05	0.0103	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	9.89e-05	0.0029	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL10—ulcerative colitis	9.81e-05	0.00287	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—PTGS1—ulcerative colitis	9.69e-05	0.00284	CbGpPWpGaD
Mebendazole—Rash—Azathioprine—ulcerative colitis	9.67e-05	0.01	CcSEcCtD
Mebendazole—Dermatitis—Azathioprine—ulcerative colitis	9.66e-05	0.01	CcSEcCtD
Mebendazole—Angioedema—Dexamethasone—ulcerative colitis	9.5e-05	0.00985	CcSEcCtD
Mebendazole—Angioedema—Betamethasone—ulcerative colitis	9.5e-05	0.00985	CcSEcCtD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	9.37e-05	0.00275	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	9.26e-05	0.00271	CbGpPWpGaD
Mebendazole—Convulsion—Betamethasone—ulcerative colitis	9.01e-05	0.00934	CcSEcCtD
Mebendazole—Convulsion—Dexamethasone—ulcerative colitis	9.01e-05	0.00934	CcSEcCtD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.98e-05	0.00263	CbGpPWpGaD
Mebendazole—Rash—Mesalazine—ulcerative colitis	8.81e-05	0.00913	CcSEcCtD
Mebendazole—Dermatitis—Mesalazine—ulcerative colitis	8.8e-05	0.00912	CcSEcCtD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	8.5e-05	0.00249	CbGpPWpGaD
Mebendazole—Angioedema—Prednisone—ulcerative colitis	8.28e-05	0.00857	CcSEcCtD
Mebendazole—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	8.13e-05	0.00842	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—MMP1—ulcerative colitis	8.09e-05	0.00237	CbGpPWpGaD
Mebendazole—Urticaria—Prednisolone—ulcerative colitis	8.08e-05	0.00837	CcSEcCtD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	7.99e-05	0.00234	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	7.9e-05	0.00231	CbGpPWpGaD
Mebendazole—Urticaria—Hydrocortisone—ulcerative colitis	7.89e-05	0.00818	CcSEcCtD
Mebendazole—TUBB4B—Metabolism of proteins—GHRL—ulcerative colitis	7.86e-05	0.0023	CbGpPWpGaD
Mebendazole—Abdominal pain—Hydrocortisone—ulcerative colitis	7.86e-05	0.00814	CcSEcCtD
Mebendazole—Convulsion—Prednisone—ulcerative colitis	7.85e-05	0.00813	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	7.71e-05	0.00226	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	7.63e-05	0.00791	CcSEcCtD
Mebendazole—Hypersensitivity—Prednisolone—ulcerative colitis	7.5e-05	0.00777	CcSEcCtD
Mebendazole—Urticaria—Triamcinolone—ulcerative colitis	7.43e-05	0.0077	CcSEcCtD
Mebendazole—Urticaria—Methylprednisolone—ulcerative colitis	7.42e-05	0.00768	CcSEcCtD
Mebendazole—Abdominal pain—Methylprednisolone—ulcerative colitis	7.38e-05	0.00764	CcSEcCtD
Mebendazole—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.32e-05	0.00758	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	7.2e-05	0.00211	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	7.2e-05	0.00211	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Dexamethasone—ulcerative colitis	6.94e-05	0.00719	CcSEcCtD
Mebendazole—Gastrointestinal pain—Betamethasone—ulcerative colitis	6.94e-05	0.00719	CcSEcCtD
Mebendazole—Hypersensitivity—Triamcinolone—ulcerative colitis	6.89e-05	0.00714	CcSEcCtD
Mebendazole—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.88e-05	0.00712	CcSEcCtD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	6.75e-05	0.00198	CbGpPWpGaD
Mebendazole—Urticaria—Dexamethasone—ulcerative colitis	6.74e-05	0.00699	CcSEcCtD
Mebendazole—Urticaria—Betamethasone—ulcerative colitis	6.74e-05	0.00699	CcSEcCtD
Mebendazole—Abdominal pain—Dexamethasone—ulcerative colitis	6.71e-05	0.00695	CcSEcCtD
Mebendazole—Abdominal pain—Betamethasone—ulcerative colitis	6.71e-05	0.00695	CcSEcCtD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	6.61e-05	0.00194	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	6.51e-05	0.00191	CbGpPWpGaD
Mebendazole—Rash—Prednisolone—ulcerative colitis	6.41e-05	0.00665	CcSEcCtD
Mebendazole—Dermatitis—Prednisolone—ulcerative colitis	6.41e-05	0.00664	CcSEcCtD
Mebendazole—Rash—Hydrocortisone—ulcerative colitis	6.27e-05	0.00649	CcSEcCtD
Mebendazole—Dermatitis—Hydrocortisone—ulcerative colitis	6.26e-05	0.00648	CcSEcCtD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.08e-05	0.00178	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Prednisone—ulcerative colitis	6.05e-05	0.00626	CcSEcCtD
Mebendazole—Rash—Triamcinolone—ulcerative colitis	5.9e-05	0.00611	CcSEcCtD
Mebendazole—Dermatitis—Triamcinolone—ulcerative colitis	5.89e-05	0.00611	CcSEcCtD
Mebendazole—Rash—Methylprednisolone—ulcerative colitis	5.89e-05	0.0061	CcSEcCtD
Mebendazole—Dermatitis—Methylprednisolone—ulcerative colitis	5.88e-05	0.00609	CcSEcCtD
Mebendazole—Urticaria—Prednisone—ulcerative colitis	5.87e-05	0.00608	CcSEcCtD
Mebendazole—Abdominal pain—Prednisone—ulcerative colitis	5.84e-05	0.00605	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	5.77e-05	0.00169	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.52e-05	0.00162	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.52e-05	0.00162	CbGpPWpGaD
Mebendazole—Hypersensitivity—Prednisone—ulcerative colitis	5.45e-05	0.00564	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	5.36e-05	0.00157	CbGpPWpGaD
Mebendazole—Rash—Betamethasone—ulcerative colitis	5.35e-05	0.00554	CcSEcCtD
Mebendazole—Rash—Dexamethasone—ulcerative colitis	5.35e-05	0.00554	CcSEcCtD
Mebendazole—Dermatitis—Dexamethasone—ulcerative colitis	5.35e-05	0.00554	CcSEcCtD
Mebendazole—Dermatitis—Betamethasone—ulcerative colitis	5.35e-05	0.00554	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—CXCL8—ulcerative colitis	5.2e-05	0.00153	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	5.14e-05	0.00151	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL2—ulcerative colitis	5.12e-05	0.0015	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP1—ulcerative colitis	4.89e-05	0.00143	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.77e-05	0.0014	CbGpPWpGaD
Mebendazole—Rash—Prednisone—ulcerative colitis	4.66e-05	0.00483	CcSEcCtD
Mebendazole—Dermatitis—Prednisone—ulcerative colitis	4.66e-05	0.00482	CcSEcCtD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	4.55e-05	0.00133	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.07e-05	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	4e-05	0.00117	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CHP1—ulcerative colitis	3.97e-05	0.00116	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—ulcerative colitis	3.83e-05	0.00112	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.73e-05	0.00109	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.72e-05	0.00109	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.44e-05	0.00101	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—DLD—ulcerative colitis	3.43e-05	0.00101	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CHP1—ulcerative colitis	3.17e-05	0.00093	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CXCL8—ulcerative colitis	3.14e-05	0.000921	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—DLD—ulcerative colitis	2.74e-05	0.000803	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.73e-05	0.0008	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.37e-05	0.000694	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—ulcerative colitis	2.31e-05	0.000678	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.97e-05	0.000578	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.95e-05	0.000573	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.85e-05	0.000541	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.84e-05	0.00054	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.81e-05	0.000532	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—DLD—ulcerative colitis	1.69e-05	0.000495	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS1—ulcerative colitis	1.66e-05	0.000486	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.63e-05	0.000478	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.62e-05	0.000476	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CALM3—ulcerative colitis	1.49e-05	0.000438	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.43e-05	0.000418	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.32e-05	0.000388	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.24e-05	0.000363	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CALM3—ulcerative colitis	1.19e-05	0.000349	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCB1—ulcerative colitis	1.16e-05	0.00034	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADCY5—ulcerative colitis	1.08e-05	0.000317	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADCY5—ulcerative colitis	8.65e-06	0.000254	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS1—ulcerative colitis	8.16e-06	0.000239	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—ulcerative colitis	8.08e-06	0.000237	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CALM3—ulcerative colitis	7.34e-06	0.000215	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—ulcerative colitis	7.26e-06	0.000213	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—ulcerative colitis	6.45e-06	0.000189	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—ulcerative colitis	6.35e-06	0.000186	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—ulcerative colitis	5.8e-06	0.00017	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCB1—ulcerative colitis	5.71e-06	0.000167	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADCY5—ulcerative colitis	5.33e-06	0.000156	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—ulcerative colitis	5.07e-06	0.000149	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.97e-06	0.000116	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—ulcerative colitis	3.57e-06	0.000105	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—ulcerative colitis	3.13e-06	9.16e-05	CbGpPWpGaD
